Data Foundry

Drug recalls 2022

Humalog KwikPen — Class I drug recall D-0882-2022

Completed recall by Cardinal Health Inc., reported 2022-05-25, distributed in NM. TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions du

Recall numberD-0882-2022
Product typeDrug
ClassificationClass I
StatusCompleted
Voluntary or mandatedVoluntary
Recalling firmCardinal Health Inc., Dublin, OH, United States
Recall initiated2022-04-05
Classified2022-05-19
Reported by FDA2022-05-25
DistributedNM
Quantity1 boxes
Reason classeslabeling, temperature control
NDC00002-0800, 00002-0800-01, 00002-7510, 00002-7510-01, 00002-7510-17, 00002-7516, 00002-7516-01, 00002-7516-59, 00002-7516-99, 00002-7533, 00002-7533-01, 00002-7712, 00002-7712-01, 00002-7712-27, 00002-7712-61, 00002-7714, 00002-7714-01, 00002-7714-59, 00002-7714-61, 00002-8213, 00002-8213-01, 00002-8213-05, 00002-8799, 00002-8799-01, 00002-8799-59

Product

Humalog KwikPen, Insulin lispro injection, U-100, 100 units per mL, 5x3 mL Prefilled Pens per box, Marketed by Lilly USA, LLC, Indianapolis, IN 46285, Box NDC 0002-8799-59, Pen NDC 002-7516-59

Reason for recall

TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement weather.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0882-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.